<DOC>
	<DOCNO>NCT01491360</DOCNO>
	<brief_summary>A new minimally invasive procedure treat presbyopia evaluate determine improvement near intermediate vision treatment .</brief_summary>
	<brief_title>LaserACE® Procedure Restore Visual Function Range Accommodation LaserACE® Procedure</brief_title>
	<detailed_description />
	<mesh_term>Presbyopia</mesh_term>
	<criteria>1 . Willing able understand sign inform consent ; 2 . Willing able attend postoperative examination per protocol schedule ; 3 . 50 year age great , either gender race ; 4 . Less ( &lt; ) 1.00D astigmatism eye , measure manifest refraction ; 5 . Mean refractive spherical equivalent refraction ( MRSE ) +/ 0.50D distance vision ; Note : Subjects meet criterion result prior laser refractive surgery ( LASIK , LASEK PRK ) may qualify ; however , subject must LVC procedure perform least 12 month prior LaserACE® procedure stable . 6 . Uncorrected distance visual acuity ( UDVA ) good equal 20/40 ( logMAR 0.30 ) eye , Corrected Distance Visual Acuity ( CDVA ) good equal 20/25 ( logMAR 0.10 ) eye ; 7 . Demonstrate Stereopsis 100 second arc well use Randot stereoscopic fly test reading correction ; 8 . In good ocular health exception presbyopia ; 9 . Presbyopia demonstrate : 1 . Currently wear read glass and/or bifocals ADD +1.50D ; 2 . Reduced near visual acuity correct distance ( DCNVA 20/50 ( logMAR 0.40 ) bad ; 3 . Amplitude accommodation ( AA ) 1.50D less measure minus lens test ; OR 4 . Amplitude accommodation ( AA ) 1.50D less measure iTrace aberrometer . 10 . Intraocular pressure ( IOP ) &gt; 11mmHg &lt; 30 mmHg eye without IOPlowering medication ; 11 . Less equal ( ≤ ) 0.50D difference manifest refraction cycloplegic refraction ; 12 . Stable distance refraction present , define ≤ 0.50D variation refraction 12 month prior LaserACE® procedure . Manifest refraction vary 0.50D current spectacle least 12 month age , document refraction least 12 month prior preoperative baseline exam ; 13 . Completed washout period two week ( 14 day ) prior LaserACE® procedure prior treatment : NSAIDS , blood thinner , aspirin , substance may increase bleeding ; Any antioxidant supplement ( e.g. , Vitamin B6 , Vitamin B12 , Vitamin E , Vitamin C , Acai , Ocuvite , etc ) ; Antioxidant food supplement , shitake mushroom , mushroom extract oral antioxidant . Exclusion Criteria 1 . Selfreported current pregnancy breastfeeding , plan become pregnant entire study period ; 2 . History ocular trauma prior ocular surgery , expect require retinal laser treatment ocular surgical intervention ; 3 . Presence ocular pathology cataract : Amblyopia strabismus Corneal abnormality disease Dry Eye ( International Task Force Level 3 great ) Pupil abnormality ( e.g. , corectopia , Adie 's ) Capsule zonnular abnormality Intraocular inflammation Retinal disease pathology Glaucoma ( type ) History prior ocular surgery keratorefractive surgery ; 4 . Known pathology may affect visual acuity and/or predict cause future acuity loss level 20/30 ( logMAR 0.18 ) bad ( e.g. , macular degeneration ) ; 5 . Previous radial keratotomy corneal surgery ( e.g. , corneal transplant , DSAEK/DSEK , lamellar keratoplasty ) , except LASIK , EpiLASIK/LASEK , PRK ; 6 . Previous anterior posterior chamber surgery ( e.g. , vitrectomy , laser iridotomy ) ; 7 . Keratoconus keratoconus suspect CDVA le ( &lt; ) 20/20 ( &lt; logMAR 0.00 ) distance ; 8 . Near visual acuity 40cm equivalent distance vision distance correction ( i.e. , evident effect reduce accommodative range ) ; 9 . Use systemic ocular medication may affect vision ( use miotic cycloplegic agent specifically contraindicate ) ; 10 . Acute chronic disease illness could increase operative risk confound study outcome ( ) ( e.g. , diabetes mellitus , immunocompromised , connective tissue disease ) ; 11 . Uncontrolled systemic ocular disease ; 12 . Any abnormality prevent reliable applanation tonometry EITHER eye ; 13 . Undilatable pupil one examine periphery retina ; 14 . Functional eye preference , define phoria measure 15dp horizontally and/or 2dp vertically , strabismus , suppression . 15 . History scleral ectasia , scleritis , episcleritis ; thin sclera &lt; 400 micron , determine take average three measurement ultrasound biomicroscopy ( UBM ) pachymetry ; 16 . History nuclear sclerosis LOCS III grade 2 bad and/or cataract reduce CDVA ; 17 . Known allergy study medication include topical steroid , antibiotic NSAIDS ; 18 . Per PI discretion</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Presbyopia</keyword>
	<keyword>sclera</keyword>
	<keyword>LaserACE</keyword>
</DOC>